Report overview
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients? responses to treatments.
This report contains market size and forecasts of Cancer Molecular Biomarkers in Global, including the following market information:
Global Cancer Molecular Biomarkers Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Molecular Biomarkers market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Genetic Methods Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Molecular Biomarkers include Correlogic Systems, AgendiaBv, BioMerieux, Aureon Laboratories, Astellas Pharma US, Becton, Diadexus, Abbott Laboratories and Affymetrix, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Molecular Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Molecular Biomarkers Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Molecular Biomarkers Market Segment Percentages, by Type, 2021 (%)
Genetic Methods
Protein Methods
Imaging
Global Cancer Molecular Biomarkers Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Molecular Biomarkers Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical
Medical Laboratory
Hospital
Global Cancer Molecular Biomarkers Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Molecular Biomarkers Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Molecular Biomarkers revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Molecular Biomarkers revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Correlogic Systems
AgendiaBv
BioMerieux
Aureon Laboratories
Astellas Pharma US
Becton
Diadexus
Abbott Laboratories
Affymetrix
Clarient
Biomoda
Beckman Coulter
Dickinson
